St John’s wort for depression: effective, but not with the pill

St John’s wort for depression: effective, but not with the pill
SupplementsImage de l’article

The short answer

St John’s wort performs better than placebo in mild to moderate depression, and roughly as well as conventional antidepressants in trials lasting 4 to 12 weeks. Effectiveness isn’t its problem. What it does to other medicines is: it speeds up their clearance enough to weaken a contraceptive pill, an anticoagulant or an anti-rejection treatment.

In France, it is sold without a prescription in pharmacies as a medicine. Its leaflet lists around thirty medicines or drug classes with which it is contraindicated or not recommended. In the UK, NICE, the institute that produces healthcare guidelines, tells healthcare professionals not to recommend it at all, despite the favorable evidence.

So the plant is neither a cure-all nor a placebo. It’s a genuine active ingredient, with the interactions of a genuine active ingredient, sold with the wholesome image of herbal tea.

What the trials show

St John’s wort, Hypericum perforatum, is one of the most extensively studied plants in psychiatry. The 2008 Cochrane review brought together 29 trials and 5,489 patients with major depression:

  • versus placebo: St John’s wort increases the response rate by 28% in the 9 largest trials and by 87% in the 9 smallest, a gap that signals how unstable the results are
  • versus antidepressants: it performs as well as tricyclics and selective serotonin reuptake inhibitors (SSRIs)
  • on tolerability: withdrawals due to adverse effects are substantially less frequent than with older antidepressants and SSRIs

The authors flag a geographical bias: trials conducted in German-speaking countries, where the extract is a commonly used medicine, yield more favorable results than others. All three authors also disclosed receiving fees or travel expenses from Schwabe, the German pharmaceutical company that markets Mildac, a St John’s wort medicine, in France.

Later reviews point in the same direction. In 2016, a review of 35 studies involving 6,993 patients confirmed superiority over placebo and equivalence to antidepressants, with very high heterogeneity between trials and a conclusion to be “interpreted with caution.” In 2017, a meta-analysis of 27 trials against SSRIs, involving 3,808 patients, found identical response and remission rates, and fewer withdrawals. It also noted its limitations: trials lasting 4 to 12 weeks, no evidence on severe depression or suicide risk.

The two US trials that failed

The two large US-funded trials tell a different story. In 2001, Shelton’s trial enrolled 200 patients with more pronounced major depression. After 8 weeks at 900 and then 1,200 mg per day, St John’s wort had not improved depression scores more than placebo. The remission rate was slightly higher, 14.3% versus 4.9%, but the authors themselves considered it very low.

In 2002, a trial involving 340 patients compared St John’s wort, sertraline and placebo. The plant did not beat placebo. Neither did sertraline. A trial in which the reference antidepressant fails mainly exposes its own limitations, but it does not make a case for the plant in more severe forms of depression.

The most honest reading fits into one sentence: the signal is real in mild to moderate depression, less robust beyond that, and it rests on specific extracts, not “St John’s wort” in general.

An extract is not a plant

The European Medicines Agency monograph (EMA), revised in November 2022, recognizes “well-established” use for only three dry extracts. Each is defined by its solvent, methanol or ethanol, its herb-to-extract ratio and its dose, between 600 and 1,800 mg per day depending on the extract. The indication: mild to moderate depressive episodes, with an effect expected within 4 weeks, and no use under the age of 18.

Even this document did not win unanimous support. According to the accompanying opinion, it was adopted by 19 votes out of 28. The Netherlands disputed its effectiveness itself. Italy, Greece, Hungary, Finland, Ireland and Portugal opposed traditional use because of the interactions. Hungary cited 1,919 case reports in the European pharmacovigilance database.

The practical consequence: a capsule of dried plant powder is not one of these extracts. There is no evidence that it contains the same things or works in the same way. Nor, however, is there any guarantee that it is free of interactions.

The real issue: speeding up drug clearance

To understand the danger, look at the liver and intestine. They clear most medicines using enzymes, the most important of which is called CYP3A4, and pumps that expel molecules from cells, such as P-glycoprotein.

In 2000, a study published in PNAS showed that hyperforin, a molecule in St John’s wort, very strongly activates a receptor, PXR, that controls CYP3A4 production. This enzyme is involved in the metabolism of more than half of all medicines. According to the EMA, St John’s wort also increases the activity of other enzymes and P-glycoprotein. The result: many medicines are cleared faster, their concentrations fall, and so do their effects. It takes about a week after stopping for everything to return to normal.

Low-hyperforin extracts seem less affected. A 2019 review proposes staying at or below 1 mg of hyperforin per day, while stressing that the risk cannot be ruled out. Few labels state this content.

The pill, the implant, the morning-after pill

This is the most common interaction, because it affects young, healthy women who don’t think to mention a plant. The trials show it:

  • a 2003 study involving 12 women: while taking St John’s wort, 7 had bleeding between periods, versus 2 without it, and the half-life of ethinylestradiol fell from 23.4 to 12.2 hours
  • a 2005 study involving 16 women: exposure to contraceptive pill hormones fell by 13–15%, with follicular growth and probable ovulation in some participants

In real-world use, the UK medicines regulator, the MHRA, has received 19 reports since 2000, including 4 involving implants. These included 15 unintended pregnancies. Its advice is simple: no St John’s wort with hormonal contraception.

The ANSM’s drug interaction thesaurus says the same thing: use with combined estrogen-progestogen and progestogen-only contraceptives is contraindicated. Use with ulipristal, a morning-after pill, is not recommended.

Levonorgestrel emergency contraception is affected too. In 2016, the MHRA listed St John’s wort among the products that reduce its levels. If such a product has been taken within the past 4 weeks, it recommends a copper IUD as the preferred option, or otherwise a double dose of levonorgestrel, 3 mg. That’s a decision to make with a pharmacist or doctor, not a guessing game.

Transplants, HIV, anticoagulants, cancer

The cases that alerted the medical community were striking. In 2000, The Lancet published two cases of acute heart transplant rejection after St John’s wort was added to ciclosporin, the anti-rejection treatment. That same year, in volunteers, St John’s wort reduced exposure to indinavir, an HIV treatment, by 57%.

Other studies have measured its effect on commonly used medicines:

  • warfarin, an anticoagulant: clearance increased by 29% for its most active form, with a reduced effect on coagulation
  • digoxin, a heart medicine: exposure reduced by 25% after 10 days
  • irinotecan, a chemotherapy drug: active metabolite reduced by 42%

The French list of contraindications is long. It includes vitamin K antagonists, immunosuppressants, digoxin, many cancer drugs, HIV and hepatitis C treatments, certain antiepileptics, methadone and theophylline.

One detail matters just as much as the list: stopping is dangerous too. If you take a vitamin K antagonist anticoagulant and St John’s wort, the ANSM advises against abruptly stopping the plant and calls for INR monitoring before and after stopping. Without St John’s wort, less of the medicine is cleared, its concentration rises, and so does the risk of bleeding.

With an antidepressant, the danger runs the other way

With antidepressants, the problem is reversed. St John’s wort itself acts on serotonin, and combining it with an SSRI can cause serotonin syndrome, an excess of serotonin that causes agitation, tremor and fever and, in severe cases, becomes a medical emergency. Five cases were described as early as 1999 in older people combining the two.

The French leaflet is clear: St John’s wort must not be taken with other antidepressants. The same reasoning applies to the Pill Cupboard, the pile-up of supplements taken without knowing which one does what: adding St John’s wort to a cupboard that already contains 5-HTP or griffonia means stacking two levers that act on the same molecule. The guide to supplement interactions in fact puts St John’s wort at the top of the list of risky combinations.

Skin and light

Hypericin, the plant’s red pigment, makes skin more sensitive to ultraviolet light. At usual doses, the effect remains modest. In volunteers who took 1,800 mg per day for 15 days, the UVA dose needed to produce a tan fell by about 21%. Another study involving 72 volunteers found no significant phototoxic effect up to this dose.

The French leaflet nevertheless calls for avoiding prolonged UV exposure and reports sunburn-like redness in fair skin. The Irish regulator advises against the plant during phototherapy and when using tanning beds. Something to know if you’re combining several approaches to seasonal depression.

A medicine in pharmacies, a supplement online

In France, St John’s wort has two regulatory statuses. The first is as a medicine. The public medicines database lists Mildac 300 and 600 mg from Schwabe and Prosoft 300 mg as marketed products. Mildac 600 is sold without a prescription and is not reimbursed. Its leaflet, updated in February 2024, is cautious:

  • it is “traditionally used to treat mild, temporary depressive symptoms”
  • the dosage is one tablet per day, preferably in the morning
  • the first effects appear within the first 4 weeks, and a doctor should be consulted if symptoms persist
  • it is contraindicated during pregnancy and must not be taken while breastfeeding
  • it is not recommended under the age of 18

The second status is murkier. St John’s wort does not appear on the list of plants permitted in dietary supplements established by the order of 24 June 2014, in the 2016 version I consulted. Yet St John’s wort capsules are sold as supplements, and public data confirm this.

The dietary supplement recall observatory records 9 recalls linked to St John’s wort:

  • 8 recalls for pesticides, published between 8 and 29 March 2023, covering 8 different brands, including one imposed by a prefectural order
  • 1 recall in April 2022 for a supplement that contained St John’s wort without mentioning it on the box

The second case is the most worrying. You can avoid a plant that interacts with your pill. You can’t avoid a plant that isn’t on the label.

Other countries have been stricter. Ireland removed it from over-the-counter sale in January 2000, according to the Irish Times, citing advertising, interactions with the pill and photosensitivity. It now permits a traditional medicine, provided it delivers less than 1 mg of hyperforin per day.

What the guidelines say

The clearest position comes from the UK. In its 2022 guideline on depression, NICE acknowledges that St John’s wort “may be of benefit in less severe depression.” Yet it tells healthcare professionals not to prescribe or recommend it. Its reasons:

  • uncertainty about the appropriate dose
  • uncertainty about how long the effect lasts
  • variability between preparations
  • potentially serious interactions, particularly with hormonal contraceptives, anticoagulants and antiepileptics

It’s an unusual position: an agency acknowledges a benefit and still advises against the product, because it cannot guarantee that the patient will buy the right preparation and take it safely.

If you’re considering it anyway

If your low mood is mild, you take no medication and you don’t use hormonal contraception, St John’s wort is a defensible choice, provided you follow a few rules:

  • choose a licensed medicine from a pharmacy, with an extract matching those tested, rather than a capsule of powdered herb
  • tell your pharmacist and every doctor, including about the pill, an implant, an anticoagulant or a short-term treatment such as an antibiotic or antifungal
  • switch contraception if you use a hormonal method: the MHRA advises against combining them, while non-hormonal methods such as a copper IUD or condoms are not affected
  • set a check-in at 4 weeks : that’s how long the leaflet says it takes to work, and if there’s no improvement, see a doctor
  • don’t stop on your own if you take a vitamin K antagonist anticoagulant: your INR must be checked before and after stopping
  • avoid prolonged UV exposure, tanning beds and phototherapy while taking it

Never replace a prescribed antidepressant with St John’s wort without talking to your doctor. And don’t combine them.

When to seek help

St John’s wort is only worth considering for mild low mood. Some situations are beyond self-medication:

  • call 3114 in France if you’re having suicidal thoughts or are worried about someone close to you: it’s the national suicide prevention helpline, free and available day and night. In the United States, call 988; in the UK and Ireland, call 116 123 (Samaritans); in other countries, contact your local crisis line
  • see a doctor if sadness or loss of interest lasts, gets worse or stops you from functioning, or if it persists after 4 weeks of treatment
  • seek advice before starting if you take long-term medication, have had a transplant, are being treated for HIV, cancer or epilepsy, or are pregnant or breastfeeding
  • report any bleeding between periods while taking the pill and St John’s wort: it’s a sign that your contraception may be less effective

The Verdict

Main sources


Frequently Asked Questions (FAQ)

  • Does St John’s wort work for depression?

    For mild to moderate depression, yes, with caveats. The 2008 Cochrane review, covering 29 trials and 5,489 patients, found it superior to placebo and comparable to conventional antidepressants, with fewer withdrawals due to adverse effects. Results vary widely between trials, are more favorable in German-speaking countries, and two large US trials in more pronounced depression found no effect.

  • Can you take St John’s wort with the pill?

    No. St John’s wort speeds up the clearance of contraceptive hormones. In the UK, the medicines regulator recorded 15 unintended pregnancies in women combining St John’s wort with the pill or an implant. In France, the ANSM’s drug interaction thesaurus contraindicates its use with combined estrogen-progestogen and progestogen-only contraceptives. Non-hormonal methods, such as a copper IUD or condoms, are not affected.

  • Can you combine St John’s wort with an antidepressant?

    No, unless explicitly advised by a doctor. The leaflet for Mildac, the St John’s wort medicine sold in France, states that it must not be taken with other antidepressants. The combination carries a risk of serotonin syndrome, an excess of serotonin that can be serious. Don’t replace your treatment with St John’s wort without talking to your doctor either.

  • How long does its effect on medicines last after you stop?

    According to the European Medicines Agency’s monograph, enzyme activity returns to normal about a week after stopping. For emergency contraception, the UK regulator uses a wider window: if an inducer such as St John’s wort has been taken within the past 4 weeks, it advises a copper IUD as the preferred option, or otherwise a double dose of levonorgestrel.

  • Is St John’s wort available over the counter in France?

    Yes, as a medicine sold in pharmacies without a prescription, such as Mildac 300 or 600 mg. Its leaflet describes it as traditionally used for mild, temporary depressive symptoms, contraindicates it during pregnancy and breastfeeding, and lists a page of incompatible medicines. Capsules sold as dietary supplements also exist, with less tightly regulated doses and extracts.

Partager cet article

X f in

Keep exploring

View all articles

Supplements

Elderberry for flu and colds: what the syrups are really worth

Read the article

Supplements

Echinacea for colds: what the trials really say

Read the article

Supplements

Nattokinase: dangers, interactions and warning signs

Read the article